{"id":"https://openalex.org/W2021824652","doi":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","title":"Steady-state pharmacokinetics of diltiazem and hydrochlorothiazide administered alone and in combination","display_name":"Steady-state pharmacokinetics of diltiazem and hydrochlorothiazide administered alone and in combination","publication_year":1998,"publication_date":"1998-09-01","ids":{"openalex":"https://openalex.org/W2021824652","doi":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","mag":"2021824652","pmid":"https://pubmed.ncbi.nlm.nih.gov/9737817"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","doi":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics &amp; Drug Disposition","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002299630","display_name":"Scott James Weir","orcid":"https://orcid.org/0000-0002-8020-434X","observed_orcids":["https://orcid.org/0000-0002-8020-434X"]},"institutions":[{"id":"https://openalex.org/I4405270230","display_name":"Hoechst Marion Roussel (United States)","ror":"https://ror.org/009gw3p81","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270230"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott J. Weir","raw_affiliation_strings":["North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Kansas City, MO 64137, USA. ScottWeir@HMRI.Com","North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Kansas City, MO 64137, USA. ScottWeir@HMRI.Com","institution_ids":["https://openalex.org/I4405270230"]},{"raw_affiliation_string":"North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA","institution_ids":["https://openalex.org/I4405270230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000332867","display_name":"Dan C. Dimmitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270230","display_name":"Hoechst Marion Roussel (United States)","ror":"https://ror.org/009gw3p81","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan C. Dimmitt","raw_affiliation_strings":["North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA","institution_ids":["https://openalex.org/I4405270230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110233674","display_name":"Robert C. Lanman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert C. Lanman","raw_affiliation_strings":["Kansas City Analytical Services, Inc., 12700 Johnson Drive, Shawnee, KS 66216, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kansas City Analytical Services, Inc., 12700 Johnson Drive, Shawnee, KS 66216, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039917975","display_name":"M. Bruce Morrill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270230","display_name":"Hoechst Marion Roussel (United States)","ror":"https://ror.org/009gw3p81","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Bruce Morrill","raw_affiliation_strings":["North America Biostatistics and Data Management, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North America Biostatistics and Data Management, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA","institution_ids":["https://openalex.org/I4405270230"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027822358","display_name":"Dennis H. Geising","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270230","display_name":"Hoechst Marion Roussel (United States)","ror":"https://ror.org/009gw3p81","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis H. Geising","raw_affiliation_strings":["North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North America Pharmacokinetics, Hoechst Marion Roussel, Inc., Marion Park Drive, Kansas City, MO 64137, USA","institution_ids":["https://openalex.org/I4405270230"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002299630"],"corresponding_institution_ids":["https://openalex.org/I4405270230"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.1317277,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"19","issue":"6","first_page":"365","last_page":"371"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.03460000082850456,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":1.0},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8149999976158142},{"id":"https://openalex.org/keywords/steady-state-pharmacokinetics","display_name":"steady-state pharmacokinetics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.6299999952316284},{"id":"https://openalex.org/keywords/thiazide-diuretics","display_name":"thiazide diuretics","score":0.9700000286102295},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.6620000004768372},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7639999985694885},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.32199999690055847}],"concepts":[{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.9304779171943665},{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.8691815137863159},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8141505122184753},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5875680446624756},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5864393711090088},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5369216203689575},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.454500287771225},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4319438338279724},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37264925241470337},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36528685688972473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33671772480010986},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.16029119491577148},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.09691068530082703},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.05758744478225708},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006852","descriptor_name":"Hydrochlorothiazide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006852","descriptor_name":"Hydrochlorothiazide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049993","descriptor_name":"Sodium Chloride Symporter Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049993","descriptor_name":"Sodium Chloride Symporter Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","doi":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.0.co;2-r","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics &amp; Drug Disposition","raw_type":"journal-article"},{"id":"doi:10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.3.co;2-i","doi":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.3.co;2-i","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1099-081x(199809)19:6<365::aid-bdd112>3.3.co;2-i","pdf_url":null,"source":{"id":"https://openalex.org/S57691945","display_name":"Biopharmaceutics & Drug Disposition","issn_l":"0142-2782","issn":["0142-2782","1099-081X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics &amp; Drug Disposition","raw_type":"journal-article"},{"id":"pmid:9737817","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9737817","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biopharmaceutics & drug disposition","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2005701339","https://openalex.org/W2074999857","https://openalex.org/W147216824","https://openalex.org/W1593800702","https://openalex.org/W2235220327","https://openalex.org/W2102243663","https://openalex.org/W2091874195","https://openalex.org/W1964097403","https://openalex.org/W2975264596","https://openalex.org/W2054717757"],"abstract_inverted_index":{"Diltiazem":[0],"and":[1,29,49,61,74,80,87,91,100,231],"hydrochlorothiazide":[2,50,105,180,232],"are":[3],"widely":[4],"used":[5],"to":[6,19,68,129],"treat":[7],"cardiovascular":[8],"disease,":[9],"often":[10],"in":[11,62],"combination.":[12],"The":[13],"purpose":[14],"of":[15,39,171],"this":[16],"investigation":[17],"was":[18,82,97],"determine":[20],"whether":[21],"a":[22,32,224],"drug-drug":[23],"pharmacokinetic":[24,227],"interaction":[25,228],"exists":[26],"between":[27,229],"diltiazem":[28,40,88,113,172,230],"hydrochlorothiazide.":[30,103],"In":[31,222],"randomized,":[33],"crossover,":[34],"open":[35],"study,":[36],"multiple":[37],"doses":[38],"(60":[41],"mg":[42,52],"four":[43],"times":[44],"daily":[45,54],"for":[46,55,84,102],"21":[47],"doses)":[48,57],"(25":[51],"twice":[53],"11":[56],"were":[58,78],"administered":[59],"alone":[60],"combination":[63],"on":[64],"three":[65],"separate":[66],"occasions":[67],"20":[69],"healthy":[70],"male":[71],"volunteers.":[72],"Trough":[73],"serial":[75],"blood":[76],"samples":[77],"collected":[79,99],"plasma":[81,119,131,142],"assayed":[83],"diltiazem,":[85],"hydrochlorothiazide,":[86],"metabolites":[89],"(desacetyldiltiazem":[90],"N-desmethyldiltiazem)":[92],"using":[93],"HPLC.":[94],"Total":[95],"urine":[96],"also":[98],"quantified":[101],"Coadministered":[104],"did":[106,173],"not":[107,174,234],"significantly":[108,175],"(p":[109,176],">":[110,177],"0.05)":[111,178],"alter":[112],"(alone":[114,181],"versus":[115,123,135,147,157,166,182,186,192,197,205,211,218],"combination)":[116,183],"steady-state":[117],"maximum":[118,130],"concentration":[120,132],"(Css(max);":[121],"145":[122],"158":[124],"ng":[125,149,188,199],"mL(-1),":[126],"respectively),":[127],"time":[128],"(t(max);":[133],"3.0":[134],"2.8":[136],"h,":[137],"respectively);":[138],"area":[139],"under":[140],"the":[141],"concentration-time":[143],"curve":[144],"(AUCss;":[145],"688":[146],"771":[148],"x":[150,200],"h":[151,201],"mL(-1)),":[152,189,202],"oral":[153],"clearance":[154],"(Cl(oral);":[155],"96.2":[156],"88.0":[158],"L":[159,207,220],"h(-1)),":[160],"or":[161,214],"elimination":[162],"half-life":[163],"(t(1/2);":[164],"5.2":[165,167],"h).":[168],"Similarly,":[169],"administration":[170],"influence":[179],"Css(max)":[184],"(221":[185],"288":[187],"t(max)":[190],"(1.8":[191],"2.0":[193],"h),":[194,213],"AUCss":[195],"(1194":[196],"1247":[198],"Cl(oral)":[203],"(22.4":[204],"21.2":[206],"h(-1));":[208],"t(1/2)":[209],"(9.8":[210],"9.6":[212],"renal":[215],"Cl":[216],"(15.5":[217],"15.2":[219],"h(-1)).":[221],"conclusion,":[223],"clinically":[225],"significant":[226],"does":[233],"exist.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}